Reset filters
  • 23 July 2009

Boosted and unboosted atazanavir maintain viral suppression equally well

Read the article
  • 23 July 2009

Boosted darunavir monotherapy works well in two studies

Read the article
  • 23 July 2009

Aciclovir reduces disease progression and death in people with HIV by nearly 20 per cent

Read the article
  • 23 July 2009

Delays in starting treatment common in ART programmes

Read the article
  • 22 July 2009

Experimental integrase inhibitor GSK-572 looks good in early studies

Read the article
  • 22 July 2009

Lopinavir/ritonavir cost-effective first-line after single-dose nevirapine in South Africa

Read the article
  • 22 July 2009

Once-daily Kaletra as safe and effective as twice-daily dosing

Read the article
  • 22 July 2009

`Test and treat` unlikely to halt Washington epidemic

Read the article
  • 21 July 2009

Two new analyses add to abacavir cardiovascular risk debate

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.